Biocept (BIOC) Stock Climbs | Will It Continue?

Biocept, Inc. (NASDAQ: BIOC)

Biocept has had a very interesting time in the market recently. Although the company has released several points of data that show their advancements in the cancer diagnostics space, investors just didn’t seem interested as the stock fell. However, that seems to be changing. On Friday, the stock had a relatively strong day; followed by more breakout activity today. So today, we’ll take a look at what we’re seeing in the market, talk about why we’re seeing the activity, and discuss what we can expect to see moving forward. So, let’s get right to it.

BIOC Is Climbing

BIOC Stock ChartLooking at the chart to the left, a few things become clear. Firstly, Biocept has finally reached the floor with regard to the recent declines we’ve been seeing. That happened early Friday morning. However, since then, we’ve seen the bulls take hold of the stock, driving it further and further up. It’s also important to note that we’ve hit a pivotal point with regard to resistance. Following strong growth, we’ve seen a slight correction and it looks like a flag is likely to take shape in the chart. However, I strongly recommend watching that red line closely. Once this stock breaks through the $3.02 resistance line, it’s likely that we’ll see more, very strong growth.

Why Is Biocept Climbing In The First Place?

In my opinion, there are two ways this question can be answered…

  • From A Technical Standpoint – Looking at it from the technical side of the equation, it’s easy to say that after several days of slow and steady declines, the stock has reached support in the market. When this happened, BIOC started to bounce back, exciting investors and traders. As a result, the price of the stock was pushed further.
  • From A Fundamental Standpoint – From a fundamental standpoint, the climb also makes great sense. The reality is that in the past month, the company has proven to be able to detect a specific type of breast cancer using a blood sample biopsy. They’ve also added a new test to their portfolio that’s designed to pinpoint those who are likely to have lung cancer in the future. Again, these pieces of news both came out within the past month. The reality is that Biocept is a great company with great management, and a clear focus on the continuing improvement of the cancer diagnostics process…who wouldn’t invest?

Where Biocept Stock Is Likely To Move Next

I think we’re going to see great things in both the short-term and long-term outlooks of BIOC. The reality is that the company is incredibly strong fundamentally; and for the reasons mentioned above, I think we’re going to see great long term growth. As far as the short term goes, I don’t think we’ll see much downward movement. We’re likely to see a flag start to appear followed by more breakout movement in the upward direction as investors continue to get excited about this stock!

What Do You Think?

Where do you think BIOC is headed? Let us know in the comments below!

2 thoughts on “Biocept (BIOC) Stock Climbs | Will It Continue?”

  1. Good stuff, let the people know. I know that you aren’t a pumper, just a true believer in the company as I am. Revolutionary, Game Changing, these are all words that describe the way I feel about this company and what they can bring to medicine and more specifically the way we diagnose and treat cancer. As soon as they release something regarding licensing, a new partnership, a new product going to market, or anything else positive this thing will make a move you and I have been talking about for months.


Leave a Comment